New mRNA booster for covid-19
Part of Infections, Lungs & breathing clinical trials.
This study tests a new booster vaccine against COVID-19 that uses mRNA technology, similar to the Pfizer or Moderna shots. If you've already had your primary series and a booster, this could help keep your immunity strong.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 59 years old.
- You should have had a complete series of COVID-19 vaccines plus at least one booster shot, with that last booster being an mRNA vaccine (like Pfizer or Moderna) given at least 6 months ago.
- You must not have certain health conditions, such as a severe allergic reaction to vaccines, heart inflammation, or a weakened immune system.
- You must agree to use effective birth control during the study if you could become pregnant or could get a partner pregnant.
- You must be generally healthy, with no uncontrolled chronic disease or recent major surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of COVID-19 booster vaccine that targets a protein to help your immune system. It's for people who already had a primary vaccine series and at least one mRNA booster, with the last booster at least 6 months ago.
This study tests new COVID-19 booster vaccine candidates in healthy adults who previously received mRNA COVID-19 vaccines. Researchers will monitor safety and how well your immune system responds to help develop better COVID-19 protection.
This study tests an updated mRNA COVID-19 vaccine to see how well it boosts immunity and how safe it is. It may help protect you from severe COVID-19 if you are older or have certain health conditions.
This trial tests updated COVID-19 vaccines designed to better protect against current variants. It's for people who have already been vaccinated and are at higher risk for severe COVID-19.
This study tests a new type of COVID-19 vaccine that is designed to train your immune system to make stronger, longer-lasting protection. You may be able to join if you are 40–64, have already had at least two doses of a mRNA COVID-19 vaccine (Pfizer or Moderna) more than 4 months ago, and are generally healthy.
This study tests a new nasal spray COVID-19 vaccine to see how it compares to an mRNA booster shot. It is for healthy adults who have already had at least 3 doses of an mRNA COVID-19 vaccine (or 2 doses plus a confirmed COVID infection) and are looking for a needle-free booster option.
Hear when a new Severe Acute Respiratory Syndrome (SARS-CoV-2 Virus) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.